{"slideshow_credits": null, "snippet": "Senator Orrin G. Hatch objects to language that would limit brand-name drug makers&#8217; monopoly protections abroad for their cutting-edge medicines known as biologics.", "abstract": "Sen Orrin G Hatch is expressing objections to language in Trans-Pacific Partnership that would limit brand-name drug makers' monopoly protections abroad for new medications known as biologics, and has gone so far as to suggest trade deal should be renegotiated; Hatch was instrumental in negotiating trade deal, and many now question whether his stance on biologics will torpedo chances that Congress will approve deal.", "section_name": "U.S.", "print_page": "16", "document_type": "article", "byline": {"person": [{"firstname": "Jackie", "role": "reported", "lastname": "CALMES", "rank": 1, "organization": ""}], "original": "By JACKIE CALMES"}, "web_url": "http://www.nytimes.com/2015/11/13/us/politics/utah-senator-crucial-ally-for-the-pacific-rim-trade-deal-is-now-its-main-hurdle.html", "lead_paragraph": "Senator Orrin G. Hatch objects to language that would limit brand-name drug makers&#8217; monopoly protections abroad for their cutting-edge medicines known as biologics.", "headline": {"main": "Utah Senator, Crucial Ally for the Pacific Rim Trade Deal, Is Now Its Main Hurdle", "print_headline": "Utah Senator, Crucial Ally for the Pacific Rim Trade Deal, Is Now Its Main Hurdle"}, "_id": "56454eb738f0d8244c6373a8", "word_count": "1210", "multimedia": [{"height": 126, "url": "images/2015/11/13/us/13hatch/13hatch-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/13/us/13hatch/13hatch-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 399, "url": "images/2015/11/13/us/13hatch/13hatch-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/13/us/13hatch/13hatch-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "399"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/13/us/13hatch/13hatch-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/13/us/13hatch/13hatch-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-13T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Trans-Pacific Partnership", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Antitrust Laws and Competition Issues", "is_major": "Y", "rank": "3"}, {"name": "persons", "value": "Hatch, Orrin G", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "International Trade and World Market", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "6"}, {"name": "persons", "value": "Obama, Barack", "is_major": "N", "rank": "7"}, {"name": "glocations", "value": "United States", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": "Politics", "type_of_material": "News"}